Pierre Baumann - Concepedia

Author

Pierre Baumann

Also Known As

A Osberghaus, Baumann, P., Baumann, Peter, Baumann, Philipp S., Baumann, Pierre, Central Connecticut, G. Gründer, Guillaume Massy, P BAUMANN, P Baumann

Publications

15.2K

Citations

H-Index

188

Concepts

All Affiliations

Hôpital de Cery University of Lausanne University Hospital of Lausanne Klinikum Fulda

About

Pierre Baumann is an author at Hôpital de Cery specializing in medicine, pharmacology, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	43	102	6.3K
2	Health Sciences	13	13	786
3	Natural Sciences	9	9	341
4	Education	2	2	49
5	Engineering	2	2	40

Pierre Baumann

164

Publications

9.9K

Citations

H-Index

Page 1

	Year	Citations
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011 Christoph Hiemke, Pierre Baumann, N. Bergemann, Pharmacopsychiatry Psychiatric EvaluationPsychopharmacologyTdm Expert GroupPharmacotherapySocial Sciences	2011	851
The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry Pierre Baumann, Christoph Hiemke, S. Ulrich, Pharmacopsychiatry	2004	410
The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry I. Gaertner, Pierre Baumann, Christoph Hiemke, Pharmacopsychiatry Psychiatric EvaluationPsychotropic MedicationPsychopharmacologyPharmacotherapySocial Sciences	2005	343
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial Paul Sargos, Sylvie Chabaud, I. Latorzeff, The Lancet Oncology Surgical OncologyUrologyRadiation TherapyGenitourinary CancerMedicine	2020	307
Risperidone Versus Clozapine in Treatment-Resistant Chronic Schizophrenia: A Randomized Double-Blind Study Guido Bondolfi, H. Dufour, Michel Patris, American Journal of Psychiatry	1998	282
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment Séverine Crettol, Julien Déglon, Jacques Besson, Clinical Pharmacology & Therapeutics	2005	226
CGP 37849 and CGP 39551: novel and potent competitive N‐methyl‐<scp>d</scp>‐aspartate receptor antagonists with oral activity Graham E. Fagg, H.‐R. Olpe, M.F. Pozza, British Journal of Pharmacology Molecular PharmacologyCgp 37849BiochemistryMedicineSynaptic Transmission	1990	188
A Double-Blind, Placebo-Controlled Study of Citalopram With and Without Lithium in the Treatment of Therapy-Resistant Depressive Patients Pierre Baumann, R. Nil, Alain Souché, Journal of Clinical Psychopharmacology	1996	172
ABCB1 and Cytochrome P450 Polymorphisms E Jaquenoud Sirot, Branka Knežević, Gina Perla Morena, Journal of Clinical Psychopharmacology Psychotropic MedicationGeneticsHuman PolymorphismGenetic EpidemiologyMolecular Biology	2009	147
Advantages and disadvantages of combination treatment with antipsychotics Guy M. Goodwin, Wolfgang Fleischhacker, Celso Arango, European Neuropsychopharmacology PsychopathologyPsychiatryPsychotropic MedicationPsychopharmacologySchizophrenia	2009	145

Page 1